-
21 CFR Parts 210/211 - Drug GMPs
Regular price $3.95Regular price -
21 CFR Part 820 QSR with Updated 2026 QMSR
Regular price $4.95Regular price -
21 CFR Part 820 QMSR with ISO Correlation Checklist & Part 11
Regular price $16.95Regular price -
21 CFR Part 11 with Scope & Application
Regular price $5.95Regular price -
21 CFR Part 112 Produce
Regular price $5.95Regular price -
21 CFR Part 111 Dietary Supplements
Regular price $5.95Regular price -
Good Clinical Practice Handbook
Regular price $13.95Regular price -
Good Clinical Practice – Medical Device
Regular price $12.95Regular price -
8-Hour Monthly GMP Training, Certificate, GMP Handbook & e-Workbook
Regular price $39.95Regular price -
US, EU and Japanese GMPs
Regular price $18.95Regular price -
GMP Manufacturing Handbook
Regular price $17.95Regular price -
Dietary Supplement Master Handbook
Regular price $16.95Regular price -
GMP International Master Reference
Regular price $36.95Regular price -
GMP Medical Device Master Reference
Regular price $36.95Regular price -
2023 NCIMS – Grade “A” Pasteurized Milk Ordinance
Regular price $45.00Regular price -
21 CFR Part 58 - Good Laboratory Practice
Regular price $5.95Regular price -
21 CFR Part 820 2026 QMSR
Regular price $3.95Regular price -
FDA DEA GMP Master Reference Guide
Regular price $26.95Regular price -
US, Canada GMPs, ICH Q7, Q8, Q9 & Q10
Regular price $19.95Regular price -
21 CFR Part 117 - Food GMPs
Regular price $5.95Regular price -
21 CFR Parts 600, 601 610 Biologic GMP
Regular price $8.95Regular price -
EU and US GMPs with Q7 API
Regular price $13.95Regular price -
GLP Manufacturing Handbook - 4.5x7.5
Regular price $29.95Regular price -
Pharmaceutical Manufacturers GMP Audit Handbook
Regular price $12.95Regular price -
Standard Sterile Product Handbook
Regular price $10.95Regular price
All Publications
- 21 CFR Part 820 QSR with Updated 2026 QMSR
- 21 CFR Part 820 2026 QMSR
- 21 CFR Parts 210/211 - Drug GMPs
- 21 CFR Part 820 QMSR with ISO Correlation Checklist & Part 11
- GMP Manufacturing Handbook
- Dietary Supplement Master Handbook
- 21 CFR Part 117 - Food GMPs
- GMP International Master Reference
- 2023 NCIMS – Grade “A” Pasteurized Milk Ordinance
- GMP Medical Device Master Reference
- 21 CFR Part 111 Dietary Supplements
- 21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs
- Pharmaceutical Manufacturers GMP Audit Handbook
- 21 CFR Part 112 Produce
- 21 CFR Part 11 with Scope & Application
- 21 CFR 11, 210/211, 820, ICH Q7 - GMP Std Handbook
- GLP Manufacturing Handbook - 4.5x7.5
- 21 CFR Parts 600, 601 610 Biologic GMP
- 21 CFR 11, 110, 117, 120 - Food GMPs
- 21 CFR 11, 110, 111 and 117 - Food and Supplement GMPs
- FDA DEA GMP Master Reference Guide
- US, Canada GMPs, ICH Q7, Q8, Q9 & Q10
- US and EU GMPs with ICH Q7, Q8(R2), Q9(R1), Q10
- Good Clinical Practice Handbook
- 21 CFR Part 11, 58 GLP and OECD Series 1 GLP
- 21 CFR 3, 4, 11, 210/211, 820, ICH Q7 - Combination Product GMP Master
- 21 CFR 210/211 with GMP Audit Check List
- 21 CFR 1271 - Human Cells, Tissues, and Cellular and Tissue-Based Products
- 21 CFR 11, 58, 210/211, 820, ICH E6(R3) - GMP 2
- 21 CFR 11, 210/211, 700/701 - Cosmetic with "Is It Soap or a Drug"
- 21 CFR 108, 110, 113, 114 and 117 - GMPs for Low-Acid Foods
- 21 CFR Parts 11, 820 QSR with Updated 2026 QMSR
- Standard Sterile Product Handbook
- Medical Device Quality Systems Manual with 11, 820, QSR Audit Checklist, 7382.845 with QSIT
- GLP Analytical Stability Handbook - 4.5x7.5
- 21 CFR Part 4 Combination Products with 820
- 21 CFR Part 58 - Good Laboratory Practice
- EU GMPs with Annex 11, 15 - Computerized Systems and Validation
- 21 CFR 210/211 with Drug Preambles
- 21 CFR 11, 58, 210/211, 820 - Master GMP Trainer
- 21 CFR Part 822 - Postmarket Surveillance
- US, EU and Japanese GMPs
- Parts 11, 606 and 1271 - Blood, Cell & Tissue with Annex 14
- Medical Device QSIT Manual with 11, 803, 806, 820 and 821
- In Vitro Diagnostics 2017/746 Medical Devices
- EU GMPs with Annex 2 Biological
- 21 CFR Parts 112 Produce and 117 Food GMPs
- EU and US GMPs with Q7 API
- EU cGMPs for ATMP with EU GMP Chapters 1-9 and Annexes 1, 8, 11, 13, 14, 15, 16 & 19
- 21 CFR 814 - Premarket Approval of Medical Device
- 21 CFR 809 - In-Vitro Diagnostic Products
- 21 CFR 806 - Medical Devices; Reports of Corrections and Removal
- 21 CFR 606 - Blood Industry
- 21 CFR 803 - Medical Device Reporting
- 21 CFR 507 - cGMP, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals
- 21 CFR 210/211 with Keyword Index
- 21 CFR 112 - ENGLISH/SPANISH
- 21 CFR 11, 58 - Electronic Records with Scope & App. and GLP
- 21 CFR 11, 210/211 with Keyword Index
- 21 CFR 11, 210/211 - Electronic Records with Drug GMPs
- 21 CFR 11, 111 - Electronic Records with Dietary Supplement GMPs
- 21 CFR 11, 110, 117, 120, 123 - GMPs for Fish Industry
- 21 CFR 11, 101, 110, 117, 120, 123 - GMPs for Fish Industry with Food Labeling
- 8-Hour Monthly GMP Training, Certificate, GMP Handbook & e-Workbook
- 21 CFR Parts 210/211 with EU Annex 1
- 21 CFR Part 821 Medical Device Tracking Requirements
- QSIT -Quality System Inspection Technique
- 21 CFR Part 860 Medical Device Classification Procedures.
- 21 CFR Part 830 Unique Device Identification
- US, EU and Canadian Medical Device Combination
- US FDA, Canadian and European MDR
- Parts 11, 606 and 1271 - Blood Cell & Tissue GMPs
- Medical Device Quality Systems Manual with 11, 210/211, 820 and QSR Audit Checklist
- ICH Q7, ICH Q8(R2), ICH Q9(R1), ICH Q10 and ICH Q12 Combination
- ICH Q7 with Q7 Auditors Check List
- ICH Q12 Pharmaceutical Product Lifecycle Management
- GCLP Good Clinical Laboratory Handbook - 4.5x7.5
- EU Medical Device Regulation 2017-745
- EU GMPs with Annex 15 Qualification and Validation
- 503B Compounding Master Guide
- Canadian - SOR98-282 Medical Devices Regulations
- Canadian GMP Guidelines GUI-0001 July 1, 2020
- EU cGMPs for ATMP - 2018 Advanced Therapy Medicinal Products
- EU GMPs Chapter 1 - 9
- EU GMPs with Annex 1 Sterile Medicinal Products
- EU GMPs with Annex 11, 15, 16, 18, 19
- EU GMPs with Annex 14 Human Blood or Plasma Products
- 21 CFR 810 - Medical Device Recall Authority
- 21 CFR 807 - Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices
- 21 CFR 640 - Add. Standards for human blood and blood products
- 21 CFR 801 - Labeling - Medical Device
- 21 CFR 600 - Biological Products: General
- 21 CFR 58, 606 - Good Laboratory Practice for Blood Industry
- 21 CFR 4 - Regulation of Combination Products
- 21 CFR 210/211 - Drug GMPs-SPANISH
- 21 CFR 205 - Guidelines for Licensing of Wholesale Drug
- 21 CFR 110, 117, 130, 131, 133 - Milk and Dairy
- 21 CFR 117 - GMPs for Human Food - ENGLISH/SPANISH
- 21 CFR 11, 210/211, 820 with Audit Checklists - GMP Auditor’s Basic Handbook
- 21 CFR 11, 110, and 117 - Electronic Records with Food GMPs
- 21 CFR 106, 107, 110 and 117 - Infant Formula Regulations
- 21 CFR 101, 110 and 117 - Food Labeling Combination
- 2023 NCIMS – Methods for Making Sanitation Rating of Milk Shippers
- 2023 National Conference on Interstate Milk Shipments (NCIMS) 4 Book Set
- MHRA, EU & ICH GMP Handbook
- Current Good Manufacturing Practice for Medical Gases
- Audit and Training - 3 Day Onsite All-Inclusive Audit with 2 Day Training - International
- Audit and Training - 3 Day Onsite All-Inclusive Audit with 1 Day Training - International
- Audit and Training - 2 Day Onsite All-Inclusive Audit with 1 Day Training - International
- Audit and Training - 1 Day Onsite All-Inclusive Audit with 1 Day Training - International
- Training - 1 Day Onsite All Inclusive - U.S.
- Training - 3 Day Onsite All Inclusive - International
- Training - 2 Day Onsite All Inclusive - International
- Training - 3 Day Onsite All Inclusive - U.S.
- Training - 2 Day Onsite All Inclusive - U.S.
- Training - 1 Day Onsite All Inclusive - International
- Audit and Training - 3 Day Onsite All-Inclusive Audit with 2 Day Training - U.S.
- Audit and Training - 3 Day Onsite All-Inclusive Audit with 1 Day Training - U.S.
- Audit and Training - 2 Day Onsite All-Inclusive Audit with 1 Day Training - U.S.
- Audit and Training - 1 Day Onsite All-Inclusive Audit with 1 Day Training - U.S.
- Audit - 3 Day Onsite All Inclusive - International
- Audit - 2 Day Onsite All Inclusive - International
- Audit - 1 Day Onsite All Inclusive - International
- Audit - 3 Day Onsite All Inclusive - U.S.
- Audit - 2 Day Onsite All Inclusive - U.S.
- VICH GL9 Animal GCP
- Title 21 CFR Parts 1 - End Nine Volume Set
- Multi-Combo 2 - GMPs for Medical Device
- Multi-Combo 1 - GMPs for Drug, Blood and Biologic
- Medical Device Quality Systems Manual with 820 and QSR Audit Checklist
- Medical Device QSIT Manual with 11 and 820
- Medical Device Combination 2 - 21 CFR Part 11, Part 820 and EU 2017/745
- Good Clinical Practice – Medical Device
- Medical Device Clinical with EU Directive
- Japanese GMP for Drugs and Quasi-drugs - 2005
- In Vitro Diagnostics Master Handbook
- ICH S7A - Safety Pharmacology Studies for Human Pharmaceuticals
- ICH S6 - Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
- ICH S2(R1) - Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
- ICH Q9(R1) - Quality Risk Management
- ICH Q8(R2) - Pharmaceutical Development
- ICH Q7, Q8(R2), Q9(R1), Q10 and Q11
- ICH Q7, Q8(R2), Q9(R1) and Q10 with FAQ
- ICH Q7, Q8(R2), Q9(R1) and Q10 Combination
- ICH Q5E - Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process
- ICH Q2(R2) and ICH Q14 Analytical Validation
- ICH Q2(R2) Analytical Validation
- ICH Q1E - Evaluation of Stability Data
- ICH Q1D Bracketing and Matrixing Designs for Stability Testing
- ICH Q1C Stability Testing for New Dosage Forms
- ICH Q1A(R2) - Stability Testing of New Drug Substances and Products
- ICH Q14 Analytical Procedure Development
- ICH Q10 - Pharmaceutical Quality System
- ICH M3(R2) - Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
- ICH M10 Bioanalytical Method Validation
- ICH E8 - General Considerations for Clinical Studies
- ICH E6(R3) - Good Clinical Practice
- ICH E4 - Dose-Response Information to Support Drug Registration
- ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
- Audit - 1 Day Onsite All Inclusive - U.S.
- GMP - PAT Handbook
- GLP QSR Master Handbook
- Eudralex - Pharmacovigilance for Medical Products Volume 9a
- EU GMPs with ICH Q7, Q8(R2), Q9(R1) and Q10
- EU GMPs with ICH Q7
- EU GMPs with Annex 9 Manufacture of Liquids, Creams and Ointments
- EU GMPs with Annex 8 Sampling of Starting and Packaging Materials
- EU GMPs with Annex 7 Manufacture of Herbal Medicinal Products
- EU GMPs with Annex 6 Manufacture of Medicinal Gases
- EU GMPs with Annex 5 Immunolgical Vet. Products
- EU GMPs with Annex 4 Vet. products other than Immuno
- EU GMPs with Annex 3 RadioPharma
- EU GMPs with Annex 19 Reference and Retention Samples
- EU GMPs with Annex 17 Parametric Release
- EU GMPs with Annex 16 Qualified Person and Batch Release
- 21 CFR 820 - Quality System Regulations-SPANISH
- 21 CFR Part 207 Registration
- 21 CFR Parte 117 - cGMPs for Human Food - SPANISH
- 21 CFR Parts 11, 203, 205 - PDMA
- 21 CFR Parts 112 and 117 - ENGLISH/SPANISH
- 510k and PMA Guidelines
- Chinese GMPs - NMPA - Decree 79
- Clinical Master Reference Guide
- Drug & Device GMP Desk Reference Set
- Electronic Systems Master Handbook 1
- EU and US GMPs with Annex 1
- EU and US GMPs with Annexes 11 and 15
- EU cGMPs for ATMP with EU GMP Chapters 1-9
- EU GMPs with Annex 10 Inhalation Products
- EU GMPs with Annex 11 Computerized Systems
- EU GMPs with Annex 11, 15, 16 and ICH Q7
- EU GMPs with Annex 12 Ionizing Radiation
- EU GMPs with Annex 13 Investigational medicinal Products
- 21 CFR 820 - Quality System Regulations-ENGLISH/SPANISH
- 21 CFR 812 - Investigational Device Exemptions
- 21 CFR 610 - General Biological Products Standards
- 21 CFR 660 - Add. Standards for Diagnostic Substances for Lab. Tests
- 21 CFR 680 - Additional Standards for Miscellaneous Products
- 21 CFR 601 - Licensing - Biologics
- 21 CFR 58, 820 - GLP and QSR
- 21 CFR 56 - Institutional Review Boards
- 21 CFR 54 - Financial Disclosure by Clinical Investigators
- 21 CFR 50, 54, 56 - GCP Drug Approval Handbook
- 21 CFR 50 - Protection of Human Subjects
- 21 CFR 320 - Bioavailability and Bioequivalence Requirements
- 21 CFR 316 - Orphan Drugs
- 21 CFR 314 - Applications for FDA Approval to Market a New Drug
- 21 CFR 312, 314, 511 - Human and Animal Drug Approval
- 21 CFR 312 - Investigational New Drug Application
- 21 CFR 210/211 - Drug GMPs-ENGLISH/SPANISH
- 21 CFR 203 - Prescription Drug Marketing
- 21 CFR 112 Guidance for Industry 2024
- 21 CFR 112 - Produce - SPANISH
- 21 CFR 112 with Guidance for Industry 2024
- 21 CFR 115 and 118 Egg Products
- 21 CFR 13 - Public Hearing
- 21 CFR 200 - General Drug
- 21 CFR 200, 201 - General Drug & Drug Labeling Combination
- 21 CFR 11, 606 - Electronic Systems with Blood Industry GMPs
- 21 CFR 11, 820 - Electronic Records with Quality Systems Regulations
- 21 CFR 11, 820 QSR and 830 UDI
- 21 CFR 11, 58, 820 - Electronic Records with GLP and QSR
- 21 CFR 11, 58, 210/211, 600, 601, 610, 820 - Multi-US GMPs
- 21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs-SPANISH
- 21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs -ENGLISH/SPANISH
- 21 CFR 11, 210/211 - Electronic Records with Drug GMPs-SPANISH
- 21 CFR 11, 210/211 - Electronic Records with Drug GMPs-ENGLISH/SPANISH
- 21 CFR 11, 110, 112, 117, 120 - Produce cGMPs -
- 21 CFR 11 - with Scope & Application & Computerized Systems used in Clinical Investigations
- 21 CFR 11 - Electronic Records with Scope & Application and Preambles
- 21 CFR 11 - Electronic Records with Scope & Application and Part 11 Checklist
- 2023 NCIMS – Procedures, Include the Constitution and Bylaws
- 2023 NCIMS – Evaluation of Milk Laboratories
